LINE

Text:AAAPrint
Sci-tech

心博天下城游戏帐号: China grants patent to new COVID-19 medicine

2022-05-14 13:15:32CGTN Editor : Li Yan ECNS App Download
Special: Battle Against Novel Coronavirus

本文地址:http://199.3838020.com/news/sci-tech/2022-05-14/detail-ihayhruk0773838.shtml
文章摘要:心博天下城游戏帐号,严重那府兵却是在一瞬间就高叫了起来凯旋娱乐最新版下载2020、博发国际城直营、55uc棋牌游戏网站本来就偏北。

China on Tuesday granted a patent to a new COVID-19 medicine, which is said to be able to drastically slow down the copying of the coronavirus that caused the ongoing pandemic.

The medicine, called cepharanthine (CEP), is extracted from stephania and has previously been used to treat other diseases. After the global outbreak of COVID-19, scientists found the drug also had the potential to treat the new disease.

"In simple words, if there are 15,393 viruses without CEP, there will be only one with just 10 micromole of CEP per liter," Tong Yigang, the first patentee, told Science and Technology Daily. "That means a tiny bit of CEP can stop the virus from spreading."

Tong added that CEP is one of the best inhibitors of the coronavirus humans know of.

Tong's team started looking for the best drug back in January 2020, when the outbreak started, and published their findings about CEP in March 2020, a world first.

Research teams from many other countries also published similar findings later.

But it might take more time for the drug to be sold on market.

"It's an old drug being used on a new condition," said an account on question-and-answer website zhihu.com, which claimed to be owned by Fan Huahao, the second patentee. "Companies are cautious and we need help from government."

Fan said the team have limited resources to launch clinical trials.

Canadian drug maker PharmaDrug has got permission from the U.S. Food and Drug Administration to conduct a clinical trial, which is expected to start in the second half of 2022.

Most popular in 24h

MoreTop news

MoreVideo

LINE
Back to top About Us | Jobs | Contact Us | 88msc恒峰娱乐官网
Copyright ©1999-2022 Chinanews.com. All rights reserved.
Reproduction in whole or in part without permission is prohibited.
[网上传播视听节目许可证(0106168)] [京ICP证040655号]
[申博官方代理] [京ICP备05004340号-1]
88msc恒峰娱乐官网
拉斯维加斯会员游戏 大西洋澳门官网直营 中东娱乐ag是什么网站 284万彩app下载安装 永利皇宫网站大全
bet36网上开户 竞赛游戏盘口 沙龙棋牌app下载 新濠天地在线赌博 胜博发现金网大全
亚博娱乐官方直营 千赢娱乐网上投注 威尼斯人app官方下载 88赌城娱乐城直营 圣淘沙网上投注
万达娱乐线路检测中心 超级彩票助手最新版本下载 太阳城娱乐网 sunbet申博下载 太阳城app直营网